Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae

Antonio Cannatelli, Alfonso Santos-Lopez, Tommaso Giani, Bruno Gonzalez-Zorn, Gian Maria Rossolini

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The inactivation of the mgrB gene, which encodes a negative-feedback regulator of the PhoPQ signaling system, was recently shown to be a common mutational mechanism responsible for acquired polymyxin resistance among carbapenemase-producing Klebsiella pneumoniae strains from clinical sources. In this work, we show that mgrB mutants can easily be selected in vitro from different K. pneumoniae lineages, and mgrB inactivation is not associated with a significant biological cost.

Original languageEnglish
Pages (from-to)2898-2900
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume59
Issue number5
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Polymyxins
Klebsiella pneumoniae
Costs and Cost Analysis
Gene Silencing
In Vitro Techniques
carbapenemase

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Infectious Diseases

Cite this

Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae. / Cannatelli, Antonio; Santos-Lopez, Alfonso; Giani, Tommaso; Gonzalez-Zorn, Bruno; Rossolini, Gian Maria.

In: Antimicrobial Agents and Chemotherapy, Vol. 59, No. 5, 01.05.2015, p. 2898-2900.

Research output: Contribution to journalArticle

Cannatelli, Antonio ; Santos-Lopez, Alfonso ; Giani, Tommaso ; Gonzalez-Zorn, Bruno ; Rossolini, Gian Maria. / Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae. In: Antimicrobial Agents and Chemotherapy. 2015 ; Vol. 59, No. 5. pp. 2898-2900.
@article{c1fe0f7740ee4195b12f74a49ed0fdf8,
title = "Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae",
abstract = "The inactivation of the mgrB gene, which encodes a negative-feedback regulator of the PhoPQ signaling system, was recently shown to be a common mutational mechanism responsible for acquired polymyxin resistance among carbapenemase-producing Klebsiella pneumoniae strains from clinical sources. In this work, we show that mgrB mutants can easily be selected in vitro from different K. pneumoniae lineages, and mgrB inactivation is not associated with a significant biological cost.",
author = "Antonio Cannatelli and Alfonso Santos-Lopez and Tommaso Giani and Bruno Gonzalez-Zorn and Rossolini, {Gian Maria}",
year = "2015",
month = "5",
day = "1",
doi = "10.1128/AAC.04998-14",
language = "English",
volume = "59",
pages = "2898--2900",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Polymyxin resistance caused by mgrB inactivation is not associated with significant biological cost in Klebsiella pneumoniae

AU - Cannatelli, Antonio

AU - Santos-Lopez, Alfonso

AU - Giani, Tommaso

AU - Gonzalez-Zorn, Bruno

AU - Rossolini, Gian Maria

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The inactivation of the mgrB gene, which encodes a negative-feedback regulator of the PhoPQ signaling system, was recently shown to be a common mutational mechanism responsible for acquired polymyxin resistance among carbapenemase-producing Klebsiella pneumoniae strains from clinical sources. In this work, we show that mgrB mutants can easily be selected in vitro from different K. pneumoniae lineages, and mgrB inactivation is not associated with a significant biological cost.

AB - The inactivation of the mgrB gene, which encodes a negative-feedback regulator of the PhoPQ signaling system, was recently shown to be a common mutational mechanism responsible for acquired polymyxin resistance among carbapenemase-producing Klebsiella pneumoniae strains from clinical sources. In this work, we show that mgrB mutants can easily be selected in vitro from different K. pneumoniae lineages, and mgrB inactivation is not associated with a significant biological cost.

UR - http://www.scopus.com/inward/record.url?scp=84931281649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931281649&partnerID=8YFLogxK

U2 - 10.1128/AAC.04998-14

DO - 10.1128/AAC.04998-14

M3 - Article

VL - 59

SP - 2898

EP - 2900

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 5

ER -